ArticlePharmaceutics2021

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model.

Jurij Aguiar Zdovc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.